MedPath

Evaluation study for clinical utility of multiplex molecular test.in treatment for gastrointestinal infectious disease.

Not Applicable
Conditions
Patients suspected of community-acquired intestinal tract infection treated at Nagasaki University Hospital
Registration Number
JPRN-UMIN000016514
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients considered inappropriate by the physician in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-Change in the usage of antimicrobial drug -Period of administration (prescription) of antimicrobial drug -Clinical impact rate (only in the prospective observation period)
Secondary Outcome Measures
NameTimeMethod
-Total dose of the antimicrobial drugs used (by the type of drug, strain, pathogen) -Cost analysis (cost of medical resource required for diagnosis, treatment and hospitalization) -Turn-around-time -Evaluation of testing performance of Luminex xTAG GPP -Evaluation of the degree of satisfaction of Luminex xTAG GPP in the aspect of medical care -Evaluation of the frequency of positive result in the items other than those requested for usual examination
© Copyright 2025. All Rights Reserved by MedPath